Skip to main content
. Author manuscript; available in PMC: 2010 Jun 24.
Published in final edited form as: J Am Geriatr Soc. 2008 Jul 24;56(8):1434–1441. doi: 10.1111/j.1532-5415.2008.01807.x
Elements of Financial/Personal Conflicts *Author 1 LaCroix, AZ Author 2 Lee, JS Author 3 Wu, L Author 4 Cauley, JA
Yes No Yes No Yes No Yes No
Employment or Affiliation X X X X
Grants/Funds X X X X
Honoraria X X X X
Speaker Forum X X X X
Consultant X X X X
Stocks X X X X
Royalties X X X X
Expert Testimony X X X X
Board Member X X X X
Patents X X X X
Personal Relationship X X X X
Elements of Financial/Personal Conflicts Author 5 Shlipak, MG Author 6 Ott, SM Author 7 Robbins, J Author 8 Curb, JD
Yes No Yes No Yes No Yes No
Employment or Affiliation X X X X
Grants/Funds X X X X
Honoraria X X X X
Speaker Forum X X X X
Consultant X X X X
Stocks X X X X
Royalties X X X X
Expert Testimony X X X X
Board Member X X X X
Patents X X X X
Personal Relationship X X X X
Elements of Financial/Personal Conflicts Author 9 Leboff, M Author 10 Bauer, DC Author 11 Jackson, R Author 12 Kooperberg, C Author 13 Cummings, SR
Yes No Yes No Yes No Yes No Yes No
Employment or Affiliation X X X X X
Grants/Funds X X X X X
Honoraria X X X X X
Speaker Forum X X X X X
Consultant X X X X X
Stocks X X X X X
Royalties X X X X X
Expert Testimony X X X X X
Board Member X X X X X
Patents X X X X X
Personal Relationship X X X X X
Explanations for “yes” answers in table here.
Dr. Cauley has received research support from Merck & Company, Eli Lilly & Company, Pfizer Pharmaceuticals, and Novartis Pharmaceuticals. She has also received consulting fees from Eli Lilly & Company, and Novartis Pharmaceuticals. She is on the speakers’ bureau for Merck & Co., Inc.
Dr. Leboff has an Unrestricted Center of Excellence Educational Grant funded through Abbott. She also owns stock in Amgen, but has no research activities with Amgen.
In the last five years, Dr. Bauer has received research support from Amgen, Novartis, NPS, and P&G, received speaker honoraria from Merck and Novartis, and served as a consultant for Merck and Amgen.